Linesol

Linezolid, the active ingredient in Linesol, is an oxazolidinone presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections, including skin and soft‑tissue infections, community‑acquired and hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) in adult patients.

GNH USA supplies Linesol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

- Skin and soft tissue infections: effective against MRSA and other susceptible organisms. - Community‑acquired bacterial pneumonia: provides coverage for typical and atypical pathogens. - Hospital‑acquired (nosocomial) pneumonia: active against resistant Gram‑positive strains. - Complicated urinary tract infections: treats infections caused by susceptible Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: indicated for proven or suspected MRSA involvement.

Linezolid may cause a range of adverse reactions, from mild to severe. Monitoring and prompt reporting of symptoms are essential.

Common Side Effects: - Nausea - Diarrhea - Headache - Vomiting - Metallic taste - Rash

Serious or Rare Side Effects: - Thrombocytopenia - Anemia - Peripheral neuropathy - Serotonin syndrome - Severe hepatic injury - Lactic acidosis

Use of Linezolid requires careful clinical assessment and monitoring to minimize risks.

- Monitor blood counts: baseline and periodic CBC recommended. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic function: use with caution in liver disease. - Avoid concomitant serotonergic agents: risk of serotonin syndrome. - Use with caution in pregnancy: limited data, risk‑benefit assessment required. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - SSRIs/SNRIs: increased risk of serotonin syndrome. - Rifampin: significant reduction of linezolid plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs: additive hematologic effects. - Anticonvulsants (e.g., carbamazepine): may lower linezolid concentrations. - Oral contraceptives: potential reduction in efficacy.